Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesCTNew benchmark helps monitor cumulative CT radiation doseThe findings highlight the need for systematic dose tracking and rigorous justification of imaging.Radiation Oncology/TherapyStudy questions routine use of radiotherapy after bone surgeryUltrasoundCEUS outshines color Doppler imaging for indeterminate kidney lesionsWomens ImagingWomen's Imaging MinnieCast, Episode 2: Risk-based vs. annual mammography screening, part 1Digital X-RayChest x-rays reveal atherosclerosis in patients undergoing amputations